ow-dose gemcitabine plus nab-paclitaxel versus standard-dose gemcitabine plus nab-paclitaxel in elderly patients with metastastic pancreatic cancer: A randomized phase II trial
Not Applicable
- Conditions
- Metastatic pancreatic cancer
- Registration Number
- JPRN-UMIN000024505
- Lead Sponsor
- Kindai University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Pulmonary fibrosis/pneumonia interstitialis 2)Serous diarrhea 3)Active infection 4)Serious complication 5)modelate or severe pleural effusion/ascites 6)Brain metastasis with sympsons 7)Active multiple primary cancer 8)Use of warfarin potassium 9)During pregnancy 10)Serious mental disorders 11)The other inappropriate case
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method